Outsourcing STREAM

  1. An Innovative Approach To Functional Outsourcing 8/27/2025

    The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

  2. Why Functional Outsourcing Is Important To Clinical Development 8/1/2025

    Craig McIlloney, Senior Vice President of Catalyst Flex, discusses why functional outsourcing is important in today's clinical development environment, how Catalyst Flex supports this, and is scalable to flex to your changing needs.

  3. Navigating The Unique Attributes Of Psychedelic Drug Development 1/22/2024

    Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

  4. Outsourcing Clinical Trial Disclosure Management 6/3/2020

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

  5. Imagine… Easier, Proactive Drug Development 2/14/2023

    Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.

  6. Successful Manufacturing Of Clinical Trial Supply 8/27/2024

    Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.

  7. The Path Forward, Altasciences' Approach To Project Management 3/19/2024

    Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

  8. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

  9. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

    Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

  10. Improving Sponsor Oversight Of The Trial Master File 2/15/2023

    In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.